Novo Nordisk has reported a phase 3 weight-management win for Wegovy in children, with two out of five kids no longer ...
In a rare divergence from its own expert panel, the FDA has granted accelerated approval to AstraZeneca’s camizestrant, ...
Roche has retained its status as the neurology drugmaker that patient groups hold in the highest esteem, once again ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results